Why Dosing Schedules Matter for Treatment Success
Understanding Wegovy Dose Schedule vs Mounjaro Progression
The Wegovy dose schedule follows a carefully designed five-step escalation over 16 weeks, starting with 0.25mg for weeks 1-4, progressing through 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), before reaching the 2.4mg maintenance dose. This gradual progression allows your body to adapt to semaglutide's GLP-1 receptor activation whilst minimising gastrointestinal side effects. In contrast, Mounjaro employs a six-dose schedule beginning at 2.5mg and potentially reaching 15mg, utilising tirzepatide's dual GIP and GLP-1 receptor mechanism. The key difference lies not just in dosing amounts, but in the underlying mechanisms—Wegovy targets GLP-1 receptors specifically, whilst Mounjaro activates both GIP and GLP-1 pathways.
Each medication's dose schedule reflects its unique pharmacological profile and clinical trial design. The Wegovy dose schedule was optimised through the STEP clinical trial programme, where the 2.4mg maintenance dose demonstrated significant efficacy alongside a reduced-calorie diet and increased physical activity. Mounjaro's dosing reflects its SURMOUNT trial data, where higher doses were necessary to achieve optimal dual-receptor activation. Understanding these dosing philosophies helps explain why direct dose comparisons aren't meaningful—each treatment's schedule is tailored to its specific mechanism of action. Your prescriber will consider factors including your medical history, current medications, and tolerance when recommending the most suitable option.
Wegovy Dose Schedule Pricing and Value Comparison
The Wegovy dose schedule costs vary by strength, with our starter dose (0.25mg) priced at £79.99, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 to reach these final prices. Our convenient bundle options include the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, providing your first three months of treatment in one order. For those requiring extended time at lower doses, our Take-It-Slow bundles offer flexibility without compromising supply continuity.
Comparing this to Mounjaro pricing reveals different cost structures reflecting each treatment's dosing requirements and manufacturing complexities. The advantage of choosing EverydayMeds for either option extends beyond pricing—our bundles provide convenience through reduced ordering frequency, Reliable Supply continuity, and single delivery coordination. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ideal for established patients. Both treatments require long-term commitment for sustained results, making cost-per-month calculations more relevant than individual pen pricing when planning your weight management journey.
Clinical Evidence Behind Each Wegovy Dose Schedule Step
The Wegovy dose schedule's effectiveness was established through the landmark STEP clinical trial programme, particularly STEP 1 where participants achieved approximately 15% average weight loss at 68 weeks when following the complete dosing protocol. The gradual escalation from 0.25mg to 2.4mg proved crucial—patients who missed dose escalation steps showed reduced efficacy compared to those following the complete schedule. Each dose level serves a specific purpose: lower doses initiate GLP-1 receptor engagement whilst higher doses provide sustained appetite regulation and satiety signalling.
Research published by Wilding et al. in the New England Journal of Medicine (2021) demonstrated that the structured Wegovy dose schedule maximises treatment benefits whilst minimising discontinuation rates due to side effects. The 16-week escalation period allows gradual adaptation to increased GLP-1 activity, reducing nausea and gastrointestinal disturbances that can occur with rapid dose increases. This evidence-based approach explains why skipping doses or accelerating the schedule isn't recommended—each step builds upon the previous one to optimise both tolerability and clinical outcomes.
How Wegovy Works Throughout the Dose Schedule
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for appetite regulation and glucose metabolism. As you progress through the Wegovy dose schedule, increasing amounts of semaglutide bind to GLP-1 receptors in your brain's appetite centres, gradually enhancing feelings of fullness after smaller meals and reducing food cravings between meals. The once-weekly injection schedule maintains consistent semaglutide levels, providing sustained appetite control throughout each dosing phase. Each dose escalation step increases receptor occupancy, intensifying the satiety signals that help reduce caloric intake naturally. The 2.4mg maintenance dose represents the optimal balance between efficacy and tolerability established through extensive clinical testing, providing sustained GLP-1 receptor activation for long-term weight management alongside dietary and lifestyle modifications.
Ordering Process for Your Chosen Wegovy Dose Schedule
Beginning your Wegovy dose schedule through EverydayMeds starts with our comprehensive 3-minute online clinical assessment, designed to capture your medical history, current medications, and weight management goals. Our qualified prescribers review each assessment within 3 working days (or 24 hours with our express service), ensuring your chosen treatment aligns with clinical guidelines and your individual circumstances. Once approved, your first dose ships via next-day delivery using our temperature-controlled cold-chain system, maintaining the medication's integrity from our GPhC-registered pharmacy (#9012878) to your door. Each subsequent dose order follows the same rigorous process, with your prescriber monitoring your progress through the escalation schedule. Our ordering system tracks your current dose level, sending reminders when it's time to progress to the next strength, ensuring you never miss a crucial step in your treatment schedule.
Storage Requirements Throughout Your Wegovy Dose Schedule
Proper storage is crucial for maintaining Wegovy's effectiveness throughout your dose schedule, with each FlexTouch pen requiring refrigeration at 2-8°C before first use. Once removed from the fridge, Wegovy maintains stability for up to 6 weeks at room temperature below 30°C, providing significant flexibility compared to Mounjaro's 21-day room temperature limit. This storage advantage proves particularly valuable during holidays, business travel, or extended periods away from refrigeration facilities. Each pen contains four doses regardless of strength, meaning your 0.25mg starter pen lasts four weeks whilst your 2.4mg maintenance pen provides one month of treatment. The FlexTouch delivery system remains consistent across all dose strengths, eliminating the need to learn new injection techniques as you progress through the escalation schedule, with each pen clearly labelled with its specific dose strength to prevent confusion.
Practical Wegovy Dose Schedule vs Mounjaro Considerations
The practical differences between following a Wegovy dose schedule versus Mounjaro's progression extend beyond simple dosing numbers to impact your daily treatment experience. Wegovy's five-dose schedule typically requires fewer dose adjustments during the initial months, with most patients reaching maintenance dosing by week 17, whilst Mounjaro's six-dose range may involve more frequent strength changes depending on individual response and tolerability. The storage advantage becomes particularly relevant for frequent travellers—Wegovy's 6-week room temperature stability versus Mounjaro's 21-day limit can significantly impact travel planning and medication security.
Injection experience differs subtly between treatments, with Wegovy's FlexTouch pen system providing consistent operation across all dose strengths, whilst Mounjaro uses Lilly's pen technology with different volume requirements at higher doses. Cost considerations vary throughout treatment phases—Wegovy's dose schedule creates predictable monthly costs once maintenance is reached, whilst Mounjaro's higher-dose potential may impact long-term budgeting. Both treatments require long-term commitment for sustained results, but the practical aspects of storage, injection experience, and cost progression can influence treatment adherence and overall satisfaction with your chosen approach.
Making Your Treatment Decision
Choosing between following a Wegovy dose schedule or Mounjaro's progression ultimately depends on your individual medical profile, lifestyle requirements, and treatment preferences discussed with your prescriber. Both medications represent significant advances in weight management, with Wegovy's established STEP trial data providing extensive real-world evidence, whilst Mounjaro's dual-receptor mechanism offers an alternative approach for patients who may benefit from GIP and GLP-1 activation. EverydayMeds' unique position as a pharmacy offering both treatments means your decision isn't limited by supply constraints or pharmacy restrictions—you can access either option with the same high standards of clinical oversight, cold-chain delivery, and ongoing support. Your prescriber will consider factors including your medical history, previous treatment responses, travel requirements, and cost considerations when recommending the most suitable option. Remember that both treatments require commitment to dietary changes and increased physical activity for optimal results, making the choice of medication just one component of your comprehensive weight management strategy. Both options are available through our streamlined ordering process at https://everydaymeds.co.uk/collections/weight-loss.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
